KSPHF:OTCMKTS
Kissei Pharmaceutical Co Ltd
24,50 $
0,00%
(0,00) 1D
1 հոկ, 10:21:43 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KSPHF...
Mkt. cap
175,23 մլրդ
Avg. vol.
20,00
Volume
0,00
52-wk high
31,90 $
52-wk low
24,50 $
Beta
13,94
Shares outstanding
46,54 մլն
No. of employees
2 հզր
Mkt. cap
175,23 մլրդ
Avg. vol.
20,00
Volume
0,00
52-wk high
31,90 $
52-wk low
24,50 $
Beta
13,94
Shares outstanding
46,54 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
ad-hoc-news.de
·
5 ժամ առաջ
Kissei discloses cyberattack: what it means for Kissei stock
Profile
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
About Kissei Pharmaceutical Co Ltd
CEOMutsuo Kanzawa
Employees1,79 հզր
Founded09 օգս, 1946 թ.
HeadquartersՄացումոտո, Nagano, Ճապոնիա
Sector-
Websitekissei.co.jp